<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2018.8798</article-id>
<article-id pub-id-type="publisher-id">mmr-17-06-7952</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of epigallocatechin-3-gallate on expression of nuclear factor erythroid 2-related factor 2 and &#x03B3;-glutamyl cysteine synthetase genes in oxidative stress-induced mouse renal tubular epithelial cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Du</surname><given-names>Xuanyi</given-names></name>
<xref rid="af1-mmr-17-06-7952" ref-type="aff">1</xref>
<xref rid="fn1-mmr-17-06-7952" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Jinfeng</given-names></name>
<xref rid="af2-mmr-17-06-7952" ref-type="aff">2</xref>
<xref rid="fn1-mmr-17-06-7952" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Sun</surname><given-names>Xiaohan</given-names></name>
<xref rid="af3-mmr-17-06-7952" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Qu</surname><given-names>Shaochuan</given-names></name>
<xref rid="af3-mmr-17-06-7952" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Haitao</given-names></name>
<xref rid="af3-mmr-17-06-7952" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Mengying</given-names></name>
<xref rid="af3-mmr-17-06-7952" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Shufen</given-names></name>
<xref rid="af3-mmr-17-06-7952" ref-type="aff">3</xref>
<xref rid="c1-mmr-17-06-7952" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Ping</given-names></name>
<xref rid="af3-mmr-17-06-7952" ref-type="aff">3</xref>
<xref rid="c1-mmr-17-06-7952" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-17-06-7952"><label>1</label>Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China</aff>
<aff id="af2-mmr-17-06-7952"><label>2</label>Department of Pediatrics, Hongqi Hospital of Mudanjiang Medical College, Mudanjiang, Heilongjiang 157011, P.R. China</aff>
<aff id="af3-mmr-17-06-7952"><label>3</label>Department of Pediatrics, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-17-06-7952"><italic>Correspondence to</italic>: Dr Ping Zhou or Dr Shufen Yang, Department of Pediatrics, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Harbin, Heilongjiang 150086, P.R. China, E-mail: <email>13796685307@163.com</email>, E-mail: <email>shufenyangcn@163.com</email></corresp>
<fn id="fn1-mmr-17-06-7952"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub"><month>06</month><year>2018</year></pub-date>
<pub-date pub-type="epub"><day>28</day><month>03</month><year>2018</year></pub-date>
<volume>17</volume>
<issue>6</issue>
<fpage>7952</fpage>
<lpage>7958</lpage>
<history>
<date date-type="received"><day>26</day><month>04</month><year>2016</year></date>
<date date-type="accepted"><day>23</day><month>03</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2018, Spandidos Publications</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>The aim of the present study was to investigate the antioxidant response mechanism of epigallocatechin-3-gallate (EGCG) in H<sub>2</sub>O<sub>2</sub>-induced mouse renal tubular epithelial cells (MRTECs). The cultured MRTECs were divided into normal, H<sub>2</sub>O<sub>2</sub> (control) and EGCG treatment groups. The MTT assay was used to assess cell viability, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR), immunocytochemical and western blot analyses were performed to detect the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and &#x03B3;-glutamyl cysteine synthetase (&#x03B3;-GCS). EGCG was able to mitigate H<sub>2</sub>O<sub>2</sub>-mediated cell damage. The RT-qPCR results demonstrated that EGCG was able to upregulate the gene expression of Nrf2 and &#x03B3;-GCS in MRTECs in a dose-dependent manner. The immunocytochemistry and western blot analyses demonstrated that EGCG was able to increase the protein expression of Nrf2 and &#x03B3;-GCS in MRTECs in a dose-dependent manner. Oxidative stress may lead to a decrease in the viability of MRTECs, while EGCG was able to promote the expression of Nrf2 and &#x03B3;-GCS in MRTECs, thereby improving the antioxidant capacity of the cells and promoting the repair of oxidative stress injury.</p>
</abstract>
<kwd-group>
<kwd>oxidative stress</kwd>
<kwd>renal tubular epithelial cells</kwd>
<kwd>nuclear factor erythroid 2-related factor 2</kwd>
<kwd>&#x03B3;-glutamyl cysteine synthetase</kwd>
<kwd>epigallocatechin-3-gallate</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Oxidative stress occurs when the body is subjected to various harmful stimuli, leading to overproduction <italic>in vivo</italic> of active molecules, including reactive oxygen species (ROS) and reactive nitrogen species. When the amount of oxidation exceeds the removal of oxide material, the oxidation and antioxidant systems are imbalanced, which leads to tissue damage. The interaction between inflammation and ROS is a principal mechanism of multiple renal diseases (<xref rid="b1-mmr-17-06-7952" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-mmr-17-06-7952" ref-type="bibr">3</xref>). The kidney is an organ with high perfusion, rich blood flow and oxygen supply, and is therefore predisposed towards the production of ROS (<xref rid="b4-mmr-17-06-7952" ref-type="bibr">4</xref>&#x2013;<xref rid="b7-mmr-17-06-7952" ref-type="bibr">7</xref>). The inhibition of ROS and ROS-mediated oxidative damage is an important consideration in clinical practice for kidney disease.</p>
<p>Nuclear factor erythroid 2-related factor 2 (Nrf2) and its cytoplasmic adapter protein Kelch-like ECH-associated protein 1 (Keap1) are the central regulators of the cellular antioxidant response. Nrf2 is able to interact with other elements of the antioxidant response, inducing the expression of antioxidant proteins and phase II detoxification enzymes, and serves an important role in cellular defense. The Keap1-Nrf2/antioxidant responsive element (ARE) signaling pathway serves a range of protective functions against cellular stress, apoptosis and inflammation (<xref rid="b8-mmr-17-06-7952" ref-type="bibr">8</xref>). However, the function of the Keap1-Nrf2/ARE pathway in renal antioxidation remains unclear.</p>
<p>Catechins are polyphenol compounds extracted from green tea, and are important natural antioxidants produced by plants (<xref rid="b9-mmr-17-06-7952" ref-type="bibr">9</xref>). Epigallocatechin-3-gallate (EGCG) is the most potent antioxidant among the catechins (<xref rid="b10-mmr-17-06-7952" ref-type="bibr">10</xref>). The present study investigated the protective effect of EGCG on oxidative injury in mouse renal tubular epithelial cells (MRTECs).</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Materials</title>
<p>MRTECs were purchased from the cell bank of the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM) with high glucose and fetal bovine serum were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The EGCG was purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). The Nrf2 (cat no. bs-1074R) and &#x03B3;-GCS (cat no. YSRIBIO-068461) rabbit anti-rat immunoglobulin (Ig)G primary antibodies were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). The streptavidin peroxidase immunocytochemical staining kit and 3,3&#x2032;-diaminobenzidine(DAB) staining reagent were purchased from ZSGB-Bio (Beijing, China). The TRIzol total RNA extracting solution was purchased from Shanghai Sangon Biological Engineering Technology and Services Co., Ltd (Shanghai, China). The PrimeScript&#x2122; RT Reagent kit was purchased from Takara Biotechnology Co., Ltd. (Dalian, China). The RT-qPCR SYBR Premix Ex Taq&#x2122; kit was purchased from Takara Biotechnology Co., Ltd. The RT-qPCR primers were designed and synthesized by Takara Biotechnology Co., Ltd.</p>
</sec>
<sec>
<title>Culturing of MRTECs and grouping</title>
<p>MRTECs were digested with 0.25&#x0025; trypsin to form a single cell suspension and cultured in DMEM containing 100 ml/l fetal bovine serum, 100 U/ml penicillin and 100 &#x00B5;g/ml streptomycin dual anti-solution, at 37&#x00B0;C in an atmosphere containing 5&#x0025; CO<sub>2</sub>. The medium was replaced every 24 h and 0.25&#x0025; trypsin was used for digestion every 3 days; passaging was performed at a ratio of 1:3. The passaged cells were inoculated uniformly and, when the cells had reached the sub-integration state, serum-free medium was added for a 12-h synchronization, followed by the addition of 1&#x0025; fetal bovine serum-containing medium for the experiments. The cells were seeded on coverslips, 6-well plates or flasks. When the cells had achieved ~80&#x0025; fusion, the serum-free medium was replaced and, according to the experimental group, different dosages of drugs were added. Each experiment was performed with &#x2265;3 different generations of cells.</p>
<p>The cultured cells were divided into the untreated normal group (N); the control group incubated with 250 &#x00B5;mol/l H<sub>2</sub>O<sub>2</sub> for 6 h (C); and the EGCG groups incubated with 250 &#x00B5;mol/l H<sub>2</sub>O<sub>2</sub>, and co-cultured with EGCG at concentrations of 5 mg/l (T1), 10 mg/l (T2) and 20 mg/l (T3).</p>
</sec>
<sec>
<title>Detection of cell viability</title>
<p>The MTT chromogenic assay was used to assess the cell viability of each group. The cells were transfected into 96-well plates, and cultured for 72 h. A total of 50 &#x00B5;l MTT (5 g/l) was added to each well and incubated for 4 h. Subsequently, the supernatant was discarded and 100 &#x00B5;l dimethyl sulfoxide was added for the detection of the absorbance at 570 nm (A570) using an automatic microplate reader. The number of viable cells was proportional to the value of A570: Live cell rate=A570 of the experimental group/A570 of the control group. Trypan blue staining was performed on the EGCG groups prior to the assay and the living cell rates were observed to be &#x003E;90&#x0025;, indicating that EGCG was non-toxic to the cells.</p>
</sec>
<sec>
<title>Detection of Nrf2 and &#x03B3;-GCS mRNA expression in MRTECs using RT-qPCR</title>
<p>TRIzol was used to extract the total RNA and reverse transcription was performed to synthesize cDNA. The primer sequences for the RT-qPCR were as follows: The upstream and downstream primers of Nrf2 were 5&#x2032;-TTGATTGACATCCTTTGG-3&#x2032; and 5&#x2032;-GTTCCTTCTGGAGTTGCT-3&#x2032;, respectively, with an amplified product of 142 bp; the upstream and downstream primers of &#x03B3;-GCS were 5&#x2032;-ATCTACCACGCAGTCAAG-3&#x2032; and 5&#x2032;-CCGCCATTCAGTAACAAC-3&#x2032;, respectively, with an amplified product of 119 bp; and the upstream and downstream primers of GAPDH-F were 5&#x2032;-GCACCGTCAAGGCTGAGAAC-3&#x2032; and 5&#x2032;-ATGGTGGTGAAGACGCCAGT3&#x2032;, respectively, with an amplified product of 142 bp. The PCR composition, reaction conditions (94&#x00B0;C for 2 min for 1 cycle, 94&#x00B0;C for 40 sec, 50&#x2013;65&#x00B0;C for 40 sec and 72&#x00B0;C for 1 min for 25&#x2013;35 cycles, and 72&#x00B0;C for 5 min for 1 cycle) and dissolution profile conditions were in accordance with the manufacturer&#x0027;s protocol.</p>
<p>The SYBR-Green 1 fluorescent dye embedment method was used to prepare the standard curves of the target genes, Nrf2 and &#x03B3;-GCS, and the housekeeping gene GAPDH. The standard curves were used to quantifying the target gene and housekeeping gene levels in the samples. Through the correction of the housekeeping gene, the relative gene expression of Nrf2 and &#x03B3;-GCS was measured in each group (<xref rid="b11-mmr-17-06-7952" ref-type="bibr">11</xref>).</p>
</sec>
<sec>
<title>Detection of Nrf2 and &#x03B3;-GCS protein expression in MRTECs using immunocytochemical analysis</title>
<p>The coverslips containing cultured cells were prepared according to the streptavidin-biotin complex test kit protocol. The primary antibodies were rabbit anti-Nrf2 and &#x03B3;-GCS polyclonal antibodies (both 1:200), which was incubated at 4&#x00B0;C overnight. After washing with PBS for 5 min 3 times, the secondary antibody was added, which was a biotinylated goat anti-rabbit IgG (1:200; Agrisera AB, V&#x00E4;nn&#x00E4;s, Sweden; cat no. AS09608), which was incubated at 37&#x00B0;C for 30 min prior to washing with PBS as before. DAB staining was subsequently performed, and the DAB developer was added and incubated for 3 min at room temperature and then the reaction was stopped by subjecting cells to running water for 1 min. Cells were then stained with hematoxylin for 15 sec. In group N, PBS was used to replace the primary antibody and all subsequent steps were the same. The existence of black/dark grey particles inside the nucleus and/or cytoplasm was considered to be positive. The optical density values were calculated using MetaMorph image analysis software.</p>
</sec>
<sec>
<title>Detection of Nrf2 and &#x03B3;-GCS protein expression in MRTECs using western blot analysis</title>
<p>Total Nrf2 nucleoprotein and &#x03B3;-GCS cytoplasmic protein was extracted using radioimmunoprecipiation assay lysis buffer (BioTeke Corporation, Beijing, China), and the assay was performed according to the manufacturer&#x0027;s protocol. 3&#x0025; SDS-PAGE 3&#x0025; gel and 10&#x0025; separation gel was used, and 10 &#x00B5;l protein was loaded per lane. The protein was then transfered to nitrocellulose membrane and blocked with 5&#x0025; skimmed milk powder at 4&#x00B0;C overnight. The primary antibodies (rabbit anti-Nrf2 and &#x03B3;-GCS polyclonal antibody) were diluted 1:1,000, incubated at 4&#x00B0;C overnight and the reaction was stopped with washing solution, then the goat anti-rabbit IgG secondary antibody was added (1:2,000) at room temperature for 1 h and stopped with washing solution as before. Staining was performed using the illuminating kit (BestBio, ShangHai; <uri xlink:href="http://bestbio.biogo.net">http://bestbio.biogo.net</uri>). Quantitative analysis was performed using Fluor Chem software (version 2.0; ProteinSimple; Bio-Techne, Minneapolis, MN, USA) and &#x03B2;-actin (1:200; cat no. A5441; Sigma-Aldrich; Merck KGaA) was used as the internal reference for the analysis, and was incubated at room temperature for 1 h.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All of the experiments were repeated &#x2265;3 times and the results are expressed as the mean &#x00B1; standard deviation. Statistical analysis was performed using SPSS software (version 13.0; SPSS, Inc., Chicago, IL, USA). One-way analysis of variance was used for the comparisons of overall and intergroup differences. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Effects of different EGCG doses on H<sub>2</sub>O<sub>2</sub>-induced MRTEC cytoactivity</title>
<p>Subsequent to 6 h treatment, in the control group, the cytoactivity of MRTECs was reduced. Among the treatment groups, at an EGCG concentration of 5 mg/l, the cytoactivity was significantly increased compared with the control group (P&#x003C;0.01); at an EGCG concentration of 10 or 20 mg/l, cytoactivity was significantly increased compared with the control group (P&#x003C;0.01). EGCG protected against the H<sub>2</sub>O<sub>2</sub>-mediated decrease in cytoactivity in a dose-dependent manner (<xref rid="tI-mmr-17-06-7952" ref-type="table">Table I</xref>).</p>
</sec>
<sec>
<title>Effects of EGCG on Nrf2 and &#x03B3;-GCS mRNA expression in MRTECs following oxidative stress</title>
<p>The standard curves of Nrf2, &#x03B3;-GCS and GAPDH were prepared, and the correlation coefficients were 0.998, 0.990 and 0.995, respectively. The linearities were good, and the fusion curves demonstrated that the specificity was good.</p>
<p>The standard curve was used to quantify the expression of Nrf2, &#x03B3;-GCS and GAPDH in the samples, and it was observed that, compared with the N group, the Nrf2 and &#x03B3;-GCS mRNA in the C group was increased; compared with the C group, the expression of Nrf2 and &#x03B3;-GCS mRNA was increased in the T1 group (P&#x003C;0.05), and in the T1 and T3 groups (P&#x003C;0.01), indicating that EGCG was able to upregulate the gene expression of Nrf2 and &#x03B3;-GCS in MRTECs in a dose-dependent manner (<xref rid="tII-mmr-17-06-7952" ref-type="table">Table II</xref>; <xref rid="f1-mmr-17-06-7952" ref-type="fig">Fig. 1</xref>).</p>
</sec>
<sec>
<title>Impact of EGCG on the expression of Nrf2 and &#x03B3;-GCS protein in MRTECs following oxidative stress</title>
<p>Nrf2-positive expression is exhibited as brown particles in the MRTECs. When stimulated with 250 &#x00B5;mol/l H<sub>2</sub>O<sub>2</sub> for 6 h, the Nrf2-positive expression increased. At increasing concentrations of EGCG, the expression of Nrf2 in the nucleus increased markedly, exhibited by deeper staining, most notably in the T3 group (<xref rid="f2-mmr-17-06-7952" ref-type="fig">Fig. 2</xref>). The &#x03B3;-GCS-positive expression is exhibited as brown particles, and also located in the cytoplasm of normal MRTECs. When stimulated with H<sub>2</sub>O<sub>2</sub> for 6 h, the &#x03B3;-GCS-positive expression increased. At increasing concentrations of EGCG, the expression of &#x03B3;-GCS in the nucleus increased markedly, exhibited by deeper staining, most notably in the T3 group (<xref rid="f3-mmr-17-06-7952" ref-type="fig">Fig. 3</xref>). Compared with the normal control group, the average optical density values in the control group and each treatment group were significantly increased (P&#x003C;0.01); compared with the H<sub>2</sub>O<sub>2</sub> control group, the average optical density values in the T1 (P&#x003C;0.05), and the T2 and T3 groups (P&#x003C;0.01) significantly increased (<xref rid="tIII-mmr-17-06-7952" ref-type="table">Table III</xref>).</p>
<p>The western blotting analysis results demonstrated that, compared with the normal group, Nrf2 and &#x03B3;-GCS protein expression in the H<sub>2</sub>O<sub>2</sub> control group significantly increased (P&#x003C;0.01). Compared with the H<sub>2</sub>O<sub>2</sub> control group, Nrf2 and &#x03B3;-GCS protein expression increased in the T1 (P&#x003C;0.05), and the T2 and T3 groups (P&#x003C;0.01), suggesting that EGCG was able to increase Nrf2 and &#x03B3;-GCS protein expression in MRTECs in a dose-dependent manner (<xref rid="tIV-mmr-17-06-7952" ref-type="table">Table IV</xref>; <xref rid="f4-mmr-17-06-7952" ref-type="fig">Fig. 4</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Studies have demonstrated that catechins exhibit therapeutic effects in immune nephritis (C-BSA nephritis and Masugi nephritis), diabetic nephropathy, renal dysfunction, chronic renal failure, and antibiotic- and heavy metal-induced acute kidney disease (<xref rid="b12-mmr-17-06-7952" ref-type="bibr">12</xref>&#x2013;<xref rid="b16-mmr-17-06-7952" ref-type="bibr">16</xref>). Catechins are efficient scavengers of ROS, and enhance the activity and complexation of antioxidant enzymes (<xref rid="b17-mmr-17-06-7952" ref-type="bibr">17</xref>,<xref rid="b18-mmr-17-06-7952" ref-type="bibr">18</xref>). Although H<sub>2</sub>O<sub>2</sub> is not a free radical, it is a highly-reactive ROS and may promote the generation of free radicals, thereby causing lipid peroxidation of biological membranes, and resulting in necrosis and apoptosis (<xref rid="b19-mmr-17-06-7952" ref-type="bibr">19</xref>,<xref rid="b20-mmr-17-06-7952" ref-type="bibr">20</xref>). In the present study, H<sub>2</sub>O<sub>2</sub> was used in MRTECs to replicate oxidative stress. The potential protective mechanism of EGCG following oxidative stress was investigated. The results of the present study demonstrated that oxidative stress led to a decrease in cell viability and an increase in apoptosis, while EGCG was able to ameliorate the H<sub>2</sub>O<sub>2</sub>-mediated cell damage, increasing cell viability and decreasing apoptosis. Following the EGCG intervention, the antioxidant capacity of the MRTECs was increased, as was the capacity of the cells to protect against and repair H<sub>2</sub>O<sub>2</sub>-mediated damage.</p>
<p>The receptor Nrf2 regulates the expression of certain target genes under conditions of oxidative stress. Studies have demonstrated that, when exposed to oxidative and/or electrophilic stress, overexpression of Nrf2 is able to upregulate the expression of target genes, and Nrf2 is more effective at activating gene expression compared with Nrf1 (<xref rid="b21-mmr-17-06-7952" ref-type="bibr">21</xref>). In addition, Nrf2-knockout mice exhibit decreased expression of target genes (<xref rid="b22-mmr-17-06-7952" ref-type="bibr">22</xref>). These previous results indicated that the Nrf2 serves an important role in the regulation of antioxidative genes and the expression of oxidative stress-induced genes.</p>
<p>The metabolism of foreign compounds or the pathological production of active may directly or indirectly interfere with the physiological functions of biological macromolecules, including DNA, proteins and lipids, and therefore serve an important role in the pathology of cancer, neurodegenerative diseases, atherosclerosis and aging. In order to combat this, cells have evolved defensive capabilities against toxic substances; for example, detoxifying enzymes and antioxidant stress protein genes are synergistically induced following exposure to nucleophilic substances and ROS (<xref rid="b23-mmr-17-06-7952" ref-type="bibr">23</xref>,<xref rid="b24-mmr-17-06-7952" ref-type="bibr">24</xref>). This antioxidant response involves cis-acting regulatory regions of target genes, also termed the ARE or electrophile response element (<xref rid="b25-mmr-17-06-7952" ref-type="bibr">25</xref>,<xref rid="b26-mmr-17-06-7952" ref-type="bibr">26</xref>). Previous studies have demonstrated that Nrf2 and its cytoplasmic adapter protein Keap1 are the central regulators of the cellular antioxidant response (<xref rid="b27-mmr-17-06-7952" ref-type="bibr">27</xref>). Experiments have demonstrated that Nrf2 is able to interact with ARE to regulate the expression of antioxidant proteins and phase II detoxifying enzymes (<xref rid="b28-mmr-17-06-7952" ref-type="bibr">28</xref>). A number of studies have demonstrated that the Keap1-Nrf2/ARE pathway exhibits broad cytoprotective effects in antitumor, neuroprotective and anti-inflammatory responses (<xref rid="b29-mmr-17-06-7952" ref-type="bibr">29</xref>,<xref rid="b30-mmr-17-06-7952" ref-type="bibr">30</xref>). These previous results suggested that the Keap1-Nrf2/ARE pathway served an important role in resisting the cell damage caused by foreign compounds, drugs and ultraviolet radiation. Nrf2 is highly expressed in detoxification organs, including the liver and kidneys, and other organs which are exposed to the outside environment, including the skin, lungs and digestive tract (<xref rid="b31-mmr-17-06-7952" ref-type="bibr">31</xref>). The Nrf2-Keap1 system is an essential part of the mechanisms of resisting environmental and endogenous stress.</p>
<p>&#x03B3;-GCS is able to catalyze the reaction between glutamic acid and cysteine to generate &#x03B3;-glutamyl cysteine, which further reacts with glycine to form glutathione (GSH). &#x03B3;-GCS is the rate-limiting enzyme in the synthesis of GSH and is the target gene of Nrf2 regulation. A previous study has demonstrated that antioxidants and exogenous toxic substances may induce the overexpression of Nrf2, and upregulate the expression of &#x03B3;-GCS (<xref rid="b32-mmr-17-06-7952" ref-type="bibr">32</xref>). Nrf2 is therefore able to regulate the expression of &#x03B3;-GCS, consequently affecting the synthesis of GSH.</p>
<p>Expression of &#x03B3;-GCS is regulated by a variety of transcription factors, which are enhanced by ARE, heavy metal response element, transcription factor AP-1 and nuclear factor-&#x03BA;B. Previous studies have demonstrated that the majority of antioxidant genes are enhanced by ARE, and that Nrfs, particularly Nrf2, are trans-acting factors of ARE, which are able to regulate the expression of antioxidant genes (<xref rid="b33-mmr-17-06-7952" ref-type="bibr">33</xref>,<xref rid="b34-mmr-17-06-7952" ref-type="bibr">34</xref>). The present study further investigated the association between the Nrf2 and &#x03B3;-GCS signaling pathway, and the effect of EGCG on oxidative stress-induced tubular epithelial cell injury. The results of the present study demonstrated that H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in MRTECs led to increased gene and protein expression of Nrf2, which further increased following treatment with EGCG. The results of the present study indicated that the regulation of Nrf2 in MRTECs primarily occurred at the transcriptional and post-transcriptional levels.</p>
<p>The present study additionally investigated the gene and protein expression of &#x03B3;-GCS in MRTECs, and the results suggested that oxidative stress promoted the expression of &#x03B3;-GCS. Treatment with EGCG was able to further promote the increase in &#x03B3;-GCS expression, indicating that oxidative stress in MRTECs may upregulate the expression of Nrf2, thereby upregulating its downstream target gene, &#x03B3;-GCS.</p>
<p>In the present study, the upregulated expression of the downstream target gene &#x03B3;-GCS during oxidative stress, through upregulation of the transcription factor Nrf2, was demonstrated to occur via the Keap1-Nrf2/ARE signaling pathway. Following treatment with EGCG, the expression of &#x03B3;-GCS and Nrf2 increased further. Therefore, the results of the present study demonstrated that EGCG was able to increase the expression of Nrf2 in a dose-dependent manner, and improve the antioxidant activity of MRTECs. In conclusion, EGCG exhibited antioxidant effects in oxidative stress-induced MRTECs in a dose-dependent manner.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by the Science and Technology Research Project of Heilongjiang Province, China (grant no. 12541324).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-17-06-7952"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>V</given-names></name><name><surname>Deep</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Palle</surname><given-names>K</given-names></name><name><surname>Yadav</surname><given-names>UC</given-names></name></person-group><article-title>Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies</article-title><source>Life Sci</source><volume>148</volume><fpage>183</fpage><lpage>193</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.lfs.2016.02.002</pub-id><pub-id pub-id-type="pmid">26851532</pub-id></element-citation></ref>
<ref id="b2-mmr-17-06-7952"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamay-Cach</surname><given-names>F</given-names></name><name><surname>Quintana-P&#x00E9;rez</surname><given-names>JC</given-names></name><name><surname>Trujillo-Ferrara</surname><given-names>JG</given-names></name><name><surname>Cuevas-Hern&#x00E1;ndez</surname><given-names>RI</given-names></name><name><surname>Del Valle-Mondrag&#x00F3;n</surname><given-names>L</given-names></name><name><surname>Garc&#x00ED;a-Trejo</surname><given-names>EM</given-names></name><name><surname>Arellano-Mendoza</surname><given-names>MG</given-names></name></person-group><article-title>A review of the impact of oxidative stress and some antioxidant therapies on renal damage</article-title><source>Ren Fail</source><volume>38</volume><fpage>171</fpage><lpage>175</lpage><year>2016</year><pub-id pub-id-type="doi">10.3109/0886022X.2015.1120097</pub-id><pub-id pub-id-type="pmid">26643776</pub-id></element-citation></ref>
<ref id="b3-mmr-17-06-7952"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindblom</surname><given-names>R</given-names></name><name><surname>Higgins</surname><given-names>G</given-names></name><name><surname>Coughlan</surname><given-names>M</given-names></name><name><surname>de Haan</surname><given-names>JB</given-names></name></person-group><article-title>Targeting mitochondria and reactive oxygen species-driven pathogenesis in diabetic nephropathy</article-title><source>Rev Diabet Stud</source><volume>12</volume><fpage>134</fpage><lpage>156</lpage><year>2015</year><pub-id pub-id-type="doi">10.1900/RDS.2015.12.134</pub-id><pub-id pub-id-type="pmid">26676666</pub-id><pub-id pub-id-type="pmcid">5397988</pub-id></element-citation></ref>
<ref id="b4-mmr-17-06-7952"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervellati</surname><given-names>F</given-names></name><name><surname>Cervellati</surname><given-names>C</given-names></name><name><surname>Romani</surname><given-names>A</given-names></name><name><surname>Cremonini</surname><given-names>E</given-names></name><name><surname>Sticozzi</surname><given-names>C</given-names></name><name><surname>Belmonte</surname><given-names>G</given-names></name><name><surname>Pessina</surname><given-names>F</given-names></name><name><surname>Valacchi</surname><given-names>G</given-names></name></person-group><article-title>Hypoxia induces cell damage via oxidative stress in retinal epithelial cells</article-title><source>Free Radic Res</source><volume>48</volume><fpage>303</fpage><lpage>312</lpage><year>2014</year><pub-id pub-id-type="doi">10.3109/10715762.2013.867484</pub-id><pub-id pub-id-type="pmid">24286355</pub-id></element-citation></ref>
<ref id="b5-mmr-17-06-7952"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>JG</given-names></name><name><surname>Saraiva</surname><given-names>N</given-names></name><name><surname>Guerreiro</surname><given-names>PS</given-names></name><name><surname>Louro</surname><given-names>H</given-names></name><name><surname>Silva</surname><given-names>MJ</given-names></name><name><surname>Miranda</surname><given-names>JP</given-names></name><name><surname>Castro</surname><given-names>M</given-names></name><name><surname>Batinic-Haberle</surname><given-names>I</given-names></name><name><surname>Fernandes</surname><given-names>AS</given-names></name><name><surname>Oliveira</surname><given-names>NG</given-names></name></person-group><article-title>Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative approach of complementary endpoints</article-title><source>Food Chem Toxicol</source><volume>87</volume><fpage>65</fpage><lpage>76</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.fct.2015.11.018</pub-id><pub-id pub-id-type="pmid">26627377</pub-id></element-citation></ref>
<ref id="b6-mmr-17-06-7952"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>K</given-names></name><name><surname>Ortega</surname><given-names>MT</given-names></name><name><surname>Jeffery</surname><given-names>B</given-names></name><name><surname>Riviere</surname><given-names>JE</given-names></name><name><surname>Monteiro-Riviere</surname><given-names>NA</given-names></name></person-group><article-title>Oxidative stress response in canine in vitro liver, kidney and intestinal models with seven potential dietary ingredients</article-title><source>Toxicol Lett</source><volume>241</volume><fpage>49</fpage><lpage>59</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.toxlet.2015.11.012</pub-id><pub-id pub-id-type="pmid">26602166</pub-id></element-citation></ref>
<ref id="b7-mmr-17-06-7952"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YE</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Lai</surname><given-names>C</given-names></name><name><surname>Stanfill</surname><given-names>A</given-names></name><name><surname>Cashion</surname><given-names>A</given-names></name></person-group><article-title>Oxidative stress is associated with weight gain in recipients at 12-months following kidney transplantation</article-title><source>Clin Biochem</source><volume>49</volume><fpage>237</fpage><lpage>242</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2015.11.002</pub-id><pub-id pub-id-type="pmid">26545907</pub-id></element-citation></ref>
<ref id="b8-mmr-17-06-7952"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>You</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name></person-group><article-title>Dimethylfumarate alleviates early brain injury and secondary cognitive deficits after experimental subarachnoid hemorrhage via activation of Keap1-Nrf2-ARE system</article-title><source>J Neurosurg</source><volume>123</volume><fpage>915</fpage><lpage>923</lpage><year>2015</year><pub-id pub-id-type="doi">10.3171/2014.11.JNS132348</pub-id><pub-id pub-id-type="pmid">25614941</pub-id></element-citation></ref>
<ref id="b9-mmr-17-06-7952"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Kume</surname><given-names>S</given-names></name><name><surname>Araki</surname><given-names>H</given-names></name><name><surname>Nakazawa</surname><given-names>J</given-names></name><name><surname>Chin-Kanasaki</surname><given-names>M</given-names></name><name><surname>Araki</surname><given-names>S</given-names></name><name><surname>Nakagawa</surname><given-names>F</given-names></name><name><surname>Koya</surname><given-names>D</given-names></name><name><surname>Haneda</surname><given-names>M</given-names></name><name><surname>Maegawa</surname><given-names>H</given-names></name><name><surname>Uzu</surname><given-names>T</given-names></name></person-group><article-title>1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells</article-title><source>Free Radic Biol Med</source><volume>89</volume><fpage>831</fpage><lpage>841</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.10.414</pub-id><pub-id pub-id-type="pmid">26482866</pub-id></element-citation></ref>
<ref id="b10-mmr-17-06-7952"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrich</surname><given-names>K</given-names></name><name><surname>Bieschke</surname><given-names>J</given-names></name></person-group><article-title>The Effect of (&#x2212;)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism</article-title><source>Adv Exp Med Biol</source><volume>863</volume><fpage>139</fpage><lpage>161</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/978-3-319-18365-7_7</pub-id><pub-id pub-id-type="pmid">26092630</pub-id><pub-id pub-id-type="pmcid">5891833</pub-id></element-citation></ref>
<ref id="b11-mmr-17-06-7952"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>E</given-names></name><name><surname>Serrano-Heras</surname><given-names>G</given-names></name><name><surname>Casta&#x00F1;o</surname><given-names>MJ</given-names></name><name><surname>Solera</surname><given-names>J</given-names></name></person-group><article-title>Real-time PCR detection chemistry</article-title><source>Clin Chim Acta</source><volume>439</volume><fpage>231</fpage><lpage>250</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.cca.2014.10.017</pub-id><pub-id pub-id-type="pmid">25451956</pub-id></element-citation></ref>
<ref id="b12-mmr-17-06-7952"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soung</surname><given-names>HS</given-names></name><name><surname>Wang</surname><given-names>MH</given-names></name><name><surname>Tseng</surname><given-names>HC</given-names></name><name><surname>Fanga</surname><given-names>HW</given-names></name><name><surname>Chang</surname><given-names>KC</given-names></name></person-group><article-title>(&#x2212;)Epigallocatechin-3-gallate decreases the stress-induced impairment of learning and memory in rats</article-title><source>Neurosci Lett</source><volume>602</volume><fpage>27</fpage><lpage>32</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.neulet.2015.06.035</pub-id><pub-id pub-id-type="pmid">26126814</pub-id></element-citation></ref>
<ref id="b13-mmr-17-06-7952"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title>Blockade of the formation of insoluble ubiquitinated protein aggregates by EGCG3&#x2032; Me in the alloxan-induced diabetic kidney</article-title><source>PLoS One</source><volume>8</volume><fpage>e75687</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0075687</pub-id><pub-id pub-id-type="pmid">24098713</pub-id><pub-id pub-id-type="pmcid">3787087</pub-id></element-citation></ref>
<ref id="b14-mmr-17-06-7952"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyung</surname><given-names>SJ</given-names></name><name><surname>DeToma</surname><given-names>AS</given-names></name><name><surname>Brender</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Vivekanandan</surname><given-names>S</given-names></name><name><surname>Kochi</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>JS</given-names></name><name><surname>Ramamoorthy</surname><given-names>A</given-names></name><name><surname>Ruotolo</surname><given-names>BT</given-names></name><name><surname>Lim</surname><given-names>MH</given-names></name></person-group><article-title>Insights into antiamyloidogenic properties of the green tea extract (&#x2212;)-epigallocatechin-3-gallate toward metal-associated amyloid-&#x03B2; species</article-title><source>Proc Natl Acad Sci USA</source><volume>110</volume><fpage>3743</fpage><lpage>3748</lpage><year>2013</year><pub-id pub-id-type="doi">10.1073/pnas.1220326110</pub-id><pub-id pub-id-type="pmid">23426629</pub-id><pub-id pub-id-type="pmcid">3593904</pub-id></element-citation></ref>
<ref id="b15-mmr-17-06-7952"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Bian</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Du</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>D</given-names></name></person-group><article-title>Epigallocatechin-3-gallate reduces tubular cell apoptosis in mice with ureteral obstruction</article-title><source>J Surg Res</source><volume>197</volume><fpage>145</fpage><lpage>154</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jss.2015.03.034</pub-id><pub-id pub-id-type="pmid">25913488</pub-id></element-citation></ref>
<ref id="b16-mmr-17-06-7952"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>CG</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>YB</given-names></name></person-group><article-title>Impact and significance of EGCG on Smad, ERK, and &#x03B2;-catenin pathways in transdifferentiation of renal tubular epithelial cells</article-title><source>Genet Mol Res</source><volume>14</volume><fpage>2551</fpage><lpage>2560</lpage><year>2015</year><pub-id pub-id-type="doi">10.4238/2015.March.30.14</pub-id><pub-id pub-id-type="pmid">25867402</pub-id></element-citation></ref>
<ref id="b17-mmr-17-06-7952"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>L</given-names></name><name><surname>Forester</surname><given-names>SC</given-names></name><name><surname>Lambert</surname><given-names>JD</given-names></name></person-group><article-title>The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (&#x2212;)-epigallocatechin-3-gallate, in oral cells</article-title><source>Mol Nutr Food Res</source><volume>58</volume><fpage>665</fpage><lpage>676</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/mnfr.201300427</pub-id><pub-id pub-id-type="pmid">24249144</pub-id></element-citation></ref>
<ref id="b18-mmr-17-06-7952"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>RZ</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>GX</given-names></name><name><surname>Li</surname><given-names>HY</given-names></name><name><surname>Zhou</surname><given-names>DW</given-names></name></person-group><article-title>Tea catechins protect goat skeletal muscle against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress by modulating expression of phase 2 antioxidant enzymes</article-title><source>J Agric Food Chem</source><volume>63</volume><fpage>7921</fpage><lpage>7928</lpage><year>2015</year><pub-id pub-id-type="doi">10.1021/acs.jafc.5b00816</pub-id><pub-id pub-id-type="pmid">26118494</pub-id></element-citation></ref>
<ref id="b19-mmr-17-06-7952"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name></person-group><article-title>Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat</article-title><source>BMC Complement Altern Med</source><volume>13</volume><fpage>228</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1472-6882-13-228</pub-id><pub-id pub-id-type="pmid">24044655</pub-id><pub-id pub-id-type="pmcid">3849621</pub-id></element-citation></ref>
<ref id="b20-mmr-17-06-7952"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>Dehydroepiandrosterone ameliorates H<sub>2</sub>O<sub>2</sub>-induced Leydig cells oxidation damage and apoptosis through inhibition of ROS production and activation of PI3K/Akt pathways</article-title><source>Int J Biochem Cell Biol</source><volume>70</volume><fpage>126</fpage><lpage>139</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.biocel.2015.11.018</pub-id><pub-id pub-id-type="pmid">26643608</pub-id></element-citation></ref>
<ref id="b21-mmr-17-06-7952"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>MA</given-names></name><name><surname>Abdel-Mageed</surname><given-names>AB</given-names></name><name><surname>Mondal</surname><given-names>D</given-names></name></person-group><article-title>The Nrf1 and Nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells</article-title><source>Cancers (Basel)</source><volume>2</volume><fpage>1354</fpage><lpage>1378</lpage><year>2010</year><pub-id pub-id-type="doi">10.3390/cancers2021354</pub-id><pub-id pub-id-type="pmid">24281119</pub-id><pub-id pub-id-type="pmcid">3835133</pub-id></element-citation></ref>
<ref id="b22-mmr-17-06-7952"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furnari</surname><given-names>MA</given-names></name><name><surname>Saw</surname><given-names>CL</given-names></name><name><surname>Kong</surname><given-names>AN</given-names></name><name><surname>Wagner</surname><given-names>GC</given-names></name></person-group><article-title>Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid</article-title><source>Brain Res Bul</source><volume>109</volume><fpage>132</fpage><lpage>142</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.brainresbull.2014.10.006</pub-id></element-citation></ref>
<ref id="b23-mmr-17-06-7952"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoi</surname><given-names>PN</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Kim</surname><given-names>KK</given-names></name><name><surname>Jung</surname><given-names>YD</given-names></name></person-group><article-title>(&#x2212;)-Epigallocatechin-3-gallate blocks nicotine-induced matrix metalloproteinase-9 expression and invasiveness via suppression of NF-&#x03BA;B and AP-1 in endothelial cells</article-title><source>Int J Oncol</source><volume>43</volume><fpage>868</fpage><lpage>876</lpage><year>2013</year><pub-id pub-id-type="doi">10.3892/ijo.2013.2006</pub-id><pub-id pub-id-type="pmid">23835612</pub-id></element-citation></ref>
<ref id="b24-mmr-17-06-7952"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Jeong</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Jung</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>WJ</given-names></name></person-group><article-title>Epigallocatechin gallate protects against nitric oxide-induced apoptosis via scavenging ROS and modulating the Bcl-2 family in human dental pulp cells</article-title><source>J Toxicol Sci</source><volume>38</volume><fpage>371</fpage><lpage>378</lpage><year>2013</year><pub-id pub-id-type="doi">10.2131/jts.38.371</pub-id><pub-id pub-id-type="pmid">23665936</pub-id></element-citation></ref>
<ref id="b25-mmr-17-06-7952"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>B</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>SM</given-names></name></person-group><article-title>Effect and mechanism of epigallocatechin-3-gallate (EGCG). against the hydrogen peroxide-induced oxidative damage in human dermal fibroblasts</article-title><source>J Cosmet Sci</source><volume>64</volume><fpage>35</fpage><lpage>44</lpage><year>2013</year><pub-id pub-id-type="pmid">23449129</pub-id></element-citation></ref>
<ref id="b26-mmr-17-06-7952"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toniolo</surname><given-names>A</given-names></name><name><surname>Buccellati</surname><given-names>C</given-names></name><name><surname>Pinna</surname><given-names>C</given-names></name><name><surname>Gaion</surname><given-names>RM</given-names></name><name><surname>Sala</surname><given-names>A</given-names></name><name><surname>Bolego</surname><given-names>C</given-names></name></person-group><article-title>Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress</article-title><source>PLoS One</source><volume>8</volume><fpage>e56683</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0056683</pub-id><pub-id pub-id-type="pmid">23441213</pub-id><pub-id pub-id-type="pmcid">3575487</pub-id></element-citation></ref>
<ref id="b27-mmr-17-06-7952"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshmukh</surname><given-names>P</given-names></name><name><surname>Unni</surname><given-names>S</given-names></name><name><surname>Krishnappa</surname><given-names>G</given-names></name><name><surname>Padmanabhan</surname><given-names>B</given-names></name></person-group><article-title>The Keap1&#x2013;Nrf2 pathway: Promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases</article-title><source>Biophys Rev</source><volume>9</volume><fpage>41</fpage><lpage>56</lpage><year>2017</year><pub-id pub-id-type="doi">10.1007/s12551-016-0244-4</pub-id><pub-id pub-id-type="pmid">28510041</pub-id></element-citation></ref>
<ref id="b28-mmr-17-06-7952"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magesh</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name></person-group><article-title>Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents</article-title><source>Med Res Rev</source><volume>32</volume><fpage>687</fpage><lpage>726</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/med.21257</pub-id><pub-id pub-id-type="pmid">22549716</pub-id><pub-id pub-id-type="pmcid">3393814</pub-id></element-citation></ref>
<ref id="b29-mmr-17-06-7952"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuishi</surname><given-names>Y</given-names></name><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>The Keap1&#x2013;Nrf2 system in cancers: Stress response and anabolic metabolism</article-title><source>Front Oncol</source><volume>2</volume><fpage>200</fpage><year>2012</year><pub-id pub-id-type="doi">10.3389/fonc.2012.00200</pub-id><pub-id pub-id-type="pmid">23272301</pub-id><pub-id pub-id-type="pmcid">3530133</pub-id></element-citation></ref>
<ref id="b30-mmr-17-06-7952"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandberg</surname><given-names>M</given-names></name><name><surname>Patil</surname><given-names>J</given-names></name><name><surname>D&#x0027;Angelo</surname><given-names>B</given-names></name><name><surname>Weber</surname><given-names>SG</given-names></name><name><surname>Mallard</surname><given-names>C</given-names></name></person-group><article-title>NRF2-regulation in brain health and disease: Implication of cerebral inflammation</article-title><source>Neuropharmacology</source><volume>79</volume><fpage>298</fpage><lpage>306</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.11.004</pub-id><pub-id pub-id-type="pmid">24262633</pub-id></element-citation></ref>
<ref id="b31-mmr-17-06-7952"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tebay</surname><given-names>LE</given-names></name><name><surname>Robertson</surname><given-names>H</given-names></name><name><surname>Durant</surname><given-names>ST</given-names></name><name><surname>Vitale</surname><given-names>SR</given-names></name><name><surname>Penning</surname><given-names>TM</given-names></name><name><surname>Dinkova-Kostova</surname><given-names>AT</given-names></name><name><surname>Hayes</surname><given-names>JD</given-names></name></person-group><article-title>Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease</article-title><source>Free Radic Biol Med</source><volume>88</volume><fpage>108</fpage><lpage>146</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.06.021</pub-id><pub-id pub-id-type="pmid">26122708</pub-id><pub-id pub-id-type="pmcid">4659505</pub-id></element-citation></ref>
<ref id="b32-mmr-17-06-7952"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x0027;Brien</surname><given-names>S</given-names></name><name><surname>Kay</surname><given-names>NE</given-names></name></person-group><article-title>Maintenance therapy for B-chronic lymphocytic leukemia</article-title><source>Clin Adv Hematol Oncol</source><volume>9</volume><fpage>22</fpage><lpage>31</lpage><year>2011</year><pub-id pub-id-type="pmid">21326143</pub-id></element-citation></ref>
<ref id="b33-mmr-17-06-7952"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muthusamy</surname><given-names>VR</given-names></name><name><surname>Kannan</surname><given-names>S</given-names></name><name><surname>Sadhaasivam</surname><given-names>K</given-names></name><name><surname>Gounder</surname><given-names>SS</given-names></name><name><surname>Davidson</surname><given-names>CJ</given-names></name><name><surname>Boeheme</surname><given-names>C</given-names></name><name><surname>Hoidal</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Rajasekaran</surname><given-names>NS</given-names></name></person-group><article-title>Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium</article-title><source>Free Radic Biol Med</source><volume>52</volume><fpage>366</fpage><lpage>376</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.10.440</pub-id><pub-id pub-id-type="pmid">22051043</pub-id></element-citation></ref>
<ref id="b34-mmr-17-06-7952"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Q</given-names></name></person-group><article-title>Role of Nrf2 in oxidative stress and toxicity</article-title><source>Annu Rev Pharmacol Toxicol</source><volume>53</volume><fpage>401</fpage><lpage>426</lpage><year>2013</year><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-011112-140320</pub-id><pub-id pub-id-type="pmid">23294312</pub-id><pub-id pub-id-type="pmcid">4680839</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-17-06-7952" position="float">
<label>Figure 1.</label>
<caption><p>Effects of EGCG on (A) Nrf2, (B) &#x03B3;-GCS and (C) GAPDH mRNA expression in MRTECs under oxidative stress. EGCG was able to upregulate the expression of Nrf2 and &#x03B3;-GCS genes in MRTECs in a dose-dependent manner. MRTECs, mouse renal tubular epithelial cells; EGCG, epigallocatechin-3-gallate; Nrf2, nuclear factor erythroid 2-related factor 2; &#x03B3;-GCS, &#x03B3;-glutamyl cysteine synthetase.</p></caption>
<graphic xlink:href="MMR-17-06-7952-g00.tif"/>
</fig>
<fig id="f2-mmr-17-06-7952" position="float">
<label>Figure 2.</label>
<caption><p>Immunocytochemical staining of Nrf2 in mouse renal tubular epithelial cells (magnification, &#x00D7;400). (A) normal group; (B) H<sub>2</sub>O<sub>2</sub> control group; (C) T1 group; (D) T2 group; (E) T3 group. Nrf2 positive expression is exhibited as black/dark grey particles. Nrf2 expression increased in the H<sub>2</sub>O<sub>2</sub> control group, and increased further in the EGCG treatment groups in a dose-dependent manner, exhibited by deeper staining. Nrf2, nuclear factor erythroid 2-related factor 2.</p></caption>
<graphic xlink:href="MMR-17-06-7952-g01.tif"/>
</fig>
<fig id="f3-mmr-17-06-7952" position="float">
<label>Figure 3.</label>
<caption><p>Immunocytochemical staining of &#x03B3;-GCS in mouse renal tubular epithelial cells (magnification, &#x00D7;400). (A) normal group; (B) H<sub>2</sub>O<sub>2</sub> control group; (C) T1 group; (D) T2 group; (E) T3 group. &#x03B3;-GCS positive expression is exhibited as brown particles. &#x03B3;-GCS expression increased in the H<sub>2</sub>O<sub>2</sub> control group, and increased further in the EGCG treatment groups in a dose-dependent manner, exhibited by deeper staining. &#x03B3;-GCS, &#x03B3;-glutamyl cysteine synthetase.</p></caption>
<graphic xlink:href="MMR-17-06-7952-g02.tif"/>
</fig>
<fig id="f4-mmr-17-06-7952" position="float">
<label>Figure 4.</label>
<caption><p>Expression of Nrf2 and &#x03B3;-GCS protein in mouse renal tubular epithelial cells using western blot analysis. N, normal group; C, H<sub>2</sub>O<sub>2</sub> control group; T1, 5 mg/l EGCG group; T2, 10 mg/l EGCG group; T3, 20 mg/l EGCG group; EGCG, epigallocatechin-3-gallate; Nrf2, nuclear factor erythroid 2-related factor 2; &#x03B3;-GCS, &#x03B3;-glutamyl cysteine synthetase.</p></caption>
<graphic xlink:href="MMR-17-06-7952-g03.tif"/>
</fig>
<table-wrap id="tI-mmr-17-06-7952" position="float">
<label>Table I.</label>
<caption><p>Effects of EGCG dose on the cytoactivity of H<sub>2</sub>O<sub>2</sub>-induced mouse renal tubular epithelial cells 6 h post-treatment.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3">EGCG treatment</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">N</th>
<th align="center" valign="bottom">C</th>
<th align="center" valign="bottom">T1</th>
<th align="center" valign="bottom">T2</th>
<th align="center" valign="bottom">T3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Cell survival rate, &#x0025;</td>
<td align="center" valign="top">93.51&#x00B1;2.27</td>
<td align="center" valign="top">56.54&#x00B1;5.42<sup><xref rid="tfn1-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">77.87&#x00B1;5.86<sup><xref rid="tfn1-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn2-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">82.41&#x00B1;5.66<sup><xref rid="tfn1-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn2-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">90.22&#x00B1;2.48<sup><xref rid="tfn1-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn2-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-17-06-7952"><label>a</label><p>P&#x003C;0.01 vs. N</p></fn>
<fn id="tfn2-mmr-17-06-7952"><label>b</label><p>P&#x003C;0.01 vs. C. N, normal control; C, H<sub>2</sub>O<sub>2</sub> control; EGCG, epigallocatechin-3-gallate; T1, treated with 5 mg/l EGCG; T2, treated with 10 mg/l EGCG; T3, treated with 20 mg/l EGCG.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-mmr-17-06-7952" position="float">
<label>Table II.</label>
<caption><p>Effects of EGCG doses on relative expression of Nrf2 and &#x03B3;-GCS mRNA in mouse renal tubular epithelial cells (n=10).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3">EGCG treatment</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">N</th>
<th align="center" valign="bottom">C</th>
<th align="center" valign="bottom">T1</th>
<th align="center" valign="bottom">T2</th>
<th align="center" valign="bottom">T3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Nrf2</td>
<td align="center" valign="top">0.0018&#x00B1;0.0002</td>
<td align="center" valign="top">0.0036&#x00B1;0.0004<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.0042&#x00B1;0.0005<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn4-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">0.0063&#x00B1;0.0005<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn5-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.0067&#x00B1;0.0006<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn5-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x03B3;-GCS</td>
<td align="center" valign="top">0.0023&#x00B1;0.002</td>
<td align="center" valign="top">0.0046&#x00B1;0.0004<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.0049&#x00B1;0.0004<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn4-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">0.0071&#x00B1;0.0005<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn5-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.0074&#x00B1;0.0005<sup><xref rid="tfn3-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn5-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-mmr-17-06-7952"><label>a</label><p>P&#x003C;0.01 vs. N</p></fn>
<fn id="tfn4-mmr-17-06-7952"><label>b</label><p>P&#x003C;0.05</p></fn>
<fn id="tfn5-mmr-17-06-7952"><label>c</label><p>P&#x003C;0.01 vs. C. N, normal control; C, H<sub>2</sub>O<sub>2</sub> control; EGCG, epigallocatechin-3-gallate; Nrf2, nuclear factor erythroid 2-related factor 2; &#x03B3;-GCS, &#x03B3;-glutamyl cysteine synthetase; T1, treated with 5 mg/l EGCG; T2, treated with 10 mg/l EGCG; T3, treated with 20 mg/l EGCG.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-mmr-17-06-7952" position="float">
<label>Table III.</label>
<caption><p>Effects of EGCG on expression of Nrf2 and &#x03B3;-GCS protein in mouse renal tubular epithelial cells measured by immunocytochemical assay (OD value).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3">EGCG treatment</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">N</th>
<th align="center" valign="bottom">C</th>
<th align="center" valign="bottom">T1</th>
<th align="center" valign="bottom">T2</th>
<th align="center" valign="bottom">T3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Nrf2</td>
<td align="center" valign="top">0.291&#x00B1;0.022</td>
<td align="center" valign="top">0.421&#x00B1;0.023<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.441&#x00B1;0.030<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn7-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">0.523&#x00B1;0.024<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn8-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.545&#x00B1;0.031<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn8-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x03B3;-GCS</td>
<td align="center" valign="top">0.340&#x00B1;0.028</td>
<td align="center" valign="top">0.482&#x00B1;0.023<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.507&#x00B1;0.017<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn7-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">0.548&#x00B1; 0.029<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn8-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.596&#x00B1;0.028<sup><xref rid="tfn6-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn8-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn6-mmr-17-06-7952"><label>a</label><p>P&#x003C;0.01 vs. N</p></fn>
<fn id="tfn7-mmr-17-06-7952"><label>b</label><p>P&#x003C;0.05</p></fn>
<fn id="tfn8-mmr-17-06-7952"><label>c</label><p>P&#x003C;0.01 vs. C. N, normal control; C, H<sub>2</sub>O<sub>2</sub> control; EGCG, epigallocatechin-3-gallate; Nrf2, nuclear factor erythroid 2-related factor 2; &#x03B3;-GCS, &#x03B3;-glutamyl cysteine synthetase; T1, treated with 5 mg/l EGCG; T2, treated with 10 mg/l EGCG; T3, treated with 20 mg/l EGCG.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIV-mmr-17-06-7952" position="float">
<label>Table IV.</label>
<caption><p>Effects of EGCG on expression of Nrf2 and &#x03B3;-GCS protein in mouse renal tubular epithelial cells measured by quantified western blotting.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3">EGCG</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">N</th>
<th align="center" valign="bottom">C</th>
<th align="center" valign="bottom">T1</th>
<th align="center" valign="bottom">T2</th>
<th align="center" valign="bottom">T3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Nrf2</td>
<td align="center" valign="top">0.044&#x00B1;0.005</td>
<td align="center" valign="top">0.083&#x00B1;0.005<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.091&#x00B1;0.006<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn10-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">0.116&#x00B1;0.007<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn11-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.121&#x00B1;0.006<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn11-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x03B3;-GCS</td>
<td align="center" valign="top">0.051&#x00B1;0.006</td>
<td align="center" valign="top">0.095&#x00B1;0.006<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.099&#x00B1;0.007<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn10-mmr-17-06-7952" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">0.126&#x00B1;0.005<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn11-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">0.132&#x00B1;0.0.006<sup><xref rid="tfn9-mmr-17-06-7952" ref-type="table-fn">a</xref>,<xref rid="tfn11-mmr-17-06-7952" ref-type="table-fn">c</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn9-mmr-17-06-7952"><label>a</label><p>P&#x003C;0.01 vs. N</p></fn>
<fn id="tfn10-mmr-17-06-7952"><label>b</label><p>P&#x003C;0.05</p></fn>
<fn id="tfn11-mmr-17-06-7952"><label>c</label><p>P&#x003C;0.01 vs. C. N, normal control; C, H<sub>2</sub>O<sub>2</sub> control; EGCG, epigallocatechin-3-gallate; Nrf2, nuclear factor erythroid 2-related factor 2; &#x03B3;-GCS, &#x03B3;-glutamyl cysteine synthetase; T1, treated with 5 mg/l EGCG; T2, treated with 10 mg/l EGCG; T3, treated with 20 mg/l EGCG.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>